CIK 0001680581
- Non-accelerated filer
- Smaller reporting company
Fulcrum Therapeutics, Inc.
Sign in to watch- Ticker
- FULC
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 474839948
- Phone
- +1 617-651-8851
- Business address
- 26 LANDSDOWNE STREET, CAMBRIDGE, MA, 02139
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-07-08 | Wallace Owen B. Chief Scientific Officer | Sale | −2,951 | $20.00 | $59K | 127,088 |
| 2020-07-08 | Wallace Owen B. Chief Scientific Officer | Exercise or conversion · Stock Option (right to buy) | −2,951 | 81,942 | ||
| 2020-07-08 | Gould Robert J | Sale | −2,500 | $20.00 | $50K | 534,845 |
| 2020-07-01 | Cadavid Diego SVP Clinical Development | Sale | −1,071 | $18.30 | $20K | 65,714 |
| 2020-06-30 | Wallace Owen B. Chief Scientific Officer | Exercise or conversion | +141 | $7.84 | $1K | 127,229 |
| 2020-06-30 | Wallace Owen B. Chief Scientific Officer | Sale | −141 | $20.00 | $3K | 127,088 |
| 2020-06-30 | Wallace Owen B. Chief Scientific Officer | Exercise or conversion · Stock Option (right to buy) | −141 | 84,893 | ||
| 2020-06-25 | Cadavid Diego SVP Clinical Development | Exercise or conversion | +1,459 | $4.83 | $7K | 68,244 |
| 2020-06-25 | Cadavid Diego SVP Clinical Development | Sale | −1,459 | $22.00 | $32K | 66,785 |
| 2020-06-25 | Cadavid Diego SVP Clinical Development | Exercise or conversion · Stock Option (right to buy) | −1,459 | 12,277 | ||
| 2020-06-25 | Gould Robert J | Sale | −2,500 | $20.80 | $52K | 537,345 |
| 2020-06-11 | LEVIN MARK J Director | Grant or award · Stock Option (right to buy) | +9,285 | 9,285 | ||
| 2020-06-11 | GERAGHTY JAMES A Director | Grant or award · Stock Option (right to buy) | +9,285 | 9,285 | ||
| 2020-06-11 | Ezekowitz Alan Director | Grant or award · Stock Option (right to buy) | +9,285 | 9,285 | ||
| 2020-06-11 | Collins James J. Director | Grant or award · Stock Option (right to buy) | +9,285 | 9,285 | ||
| 2020-06-11 | Haviland Kate Director | Grant or award · Stock Option (right to buy) | +9,285 | 9,285 | ||
| 2020-06-10 | Cadavid Diego SVP Clinical Development | Exercise or conversion | +401 | $4.83 | $2K | 67,186 |
| 2020-06-10 | Cadavid Diego SVP Clinical Development | Sale | −401 | $22.00 | $9K | 66,785 |
| 2020-06-10 | Cadavid Diego SVP Clinical Development | Exercise or conversion · Stock Option (right to buy) | −401 | 13,736 | ||
| 2020-06-09 | Gould Robert J | Sale | −156 | $20.00 | $3K | 539,845 |
Page 10 of 15 · 291 trades